Skip to main content
. 2022 May 30;14(6):1163. doi: 10.3390/pharmaceutics14061163

Figure 1.

Figure 1

Enalapril (a,b) and enalaprilat (c,d) profiles of plasma concentrations over time with serum samples normalized by dose and bodyweight in steady state conditions in patients with heart failure due to dilated cardiomyopathy (a,c, n = 23) and congenital heart disease (b,d, n = 34) where profiles were measured under steady state conditions. Profiles were grouped according to age: Age group 1: 1 day to <1 year; Age group 2: 1 year to <6 years; age group 3: 6 years to <12 years.